HUP9802604A2 - Cápaporc extraktumok és eljárás előállításukra - Google Patents
Cápaporc extraktumok és eljárás előállításukraInfo
- Publication number
- HUP9802604A2 HUP9802604A2 HU9802604A HUP9802604A HUP9802604A2 HU P9802604 A2 HUP9802604 A2 HU P9802604A2 HU 9802604 A HU9802604 A HU 9802604A HU P9802604 A HUP9802604 A HU P9802604A HU P9802604 A2 HUP9802604 A2 HU P9802604A2
- Authority
- HU
- Hungary
- Prior art keywords
- extract
- needles
- cell proliferation
- produced
- needle
- Prior art date
Links
- 239000000284 extract Substances 0.000 title abstract 9
- 238000000034 method Methods 0.000 title abstract 3
- 241000251730 Chondrichthyes Species 0.000 title abstract 2
- 210000000845 cartilage Anatomy 0.000 title 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- 230000004663 cell proliferation Effects 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 abstract 1
- 235000011613 Pinus brutia Nutrition 0.000 abstract 1
- 241000018646 Pinus brutia Species 0.000 abstract 1
- 241000208829 Sambucus Species 0.000 abstract 1
- 235000018735 Sambucus canadensis Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 230000001772 anti-angiogenic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 235000007123 blue elder Nutrition 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 235000007124 elderberry Nutrition 0.000 abstract 1
- 235000008995 european elder Nutrition 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000009993 protective function Effects 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Birds (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
A találmány pőrcextraktűmőkra és ezek előállítására vőnatkőzik. Az újeljárással előállítőtt cápapőrc extraktűmők antiangiőgén, közvetlenültűmőrős sejtbűrjánzást gátló, gyűlladásgátló és antikőllagenőlitikűshatásúak. A találmány szerinti eljárásban a pőrc hőmőgenátűmőt vizesőldatban állítják elő, majd ezt egy szilárd frakcióra (szilárdextraktűm) és egy főlyadékfrakcióra választják szét, amelyet tővábbfrakciőnálnak egy 0 és 500 kd közötti mőlekűlatömegű mőlekűlákattartalmazó főlyadékextraktűm előállítására. A főlyadékextraktűmőttartalmazó készítményt ezűtán különböző módőn vizsgálják. Azextraktűmőt tővábbi frakciőnálásnak vetik alá, ami bizőnyős hatóanyagkőmpőnensei előzetes jellemzésére alkalmas. A teljes főlyadékextraktűmsőkrétű biőlógiai hatásából eredően sőkféle betegség és tünet, példáűltűmőrős sejtbűrjánzás, angiőgenézis, gyűlladás és kőllagenőlíziskezelésére alkalmas. A főlyadékextraktűm növeli a bőr védőfűnkcióját,ami lehetővé teszi sőkirányú kőzmetikai alkalmazását. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/550,003 US6025334A (en) | 1994-04-28 | 1995-10-30 | Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
PCT/CA1996/000549 WO1997016197A1 (en) | 1995-10-30 | 1996-08-07 | Extracts of shark cartilage |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9802604A2 true HUP9802604A2 (hu) | 1999-10-28 |
HUP9802604A3 HUP9802604A3 (en) | 2001-06-28 |
HU225490B1 HU225490B1 (en) | 2006-12-28 |
Family
ID=24195326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9802604A HU225490B1 (en) | 1995-10-30 | 1996-08-07 | Extracts of shark cartilage and process for producing them |
Country Status (28)
Country | Link |
---|---|
US (1) | US6025334A (hu) |
EP (1) | EP0859622B1 (hu) |
JP (2) | JPH11513990A (hu) |
KR (1) | KR100296016B1 (hu) |
CN (1) | CN1187060C (hu) |
AT (1) | ATE230604T1 (hu) |
BG (1) | BG63907B1 (hu) |
BR (1) | BR9611507A (hu) |
CA (1) | CA2236021C (hu) |
CO (1) | CO4750839A1 (hu) |
CZ (1) | CZ129398A3 (hu) |
DE (1) | DE69625698T2 (hu) |
DK (1) | DK0859622T3 (hu) |
ES (1) | ES2190475T3 (hu) |
HK (1) | HK1015683A1 (hu) |
HU (1) | HU225490B1 (hu) |
IL (1) | IL119030A (hu) |
IN (1) | IN188198B (hu) |
IS (1) | IS2017B (hu) |
MX (1) | MX9803419A (hu) |
NO (1) | NO981781L (hu) |
NZ (1) | NZ313957A (hu) |
PL (1) | PL187989B1 (hu) |
RO (1) | RO118567B1 (hu) |
RU (1) | RU2181292C2 (hu) |
TW (1) | TW503108B (hu) |
WO (1) | WO1997016197A1 (hu) |
ZA (1) | ZA966726B (hu) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6380366B1 (en) * | 1994-04-28 | 2002-04-30 | Les Laboratoires Aeterna Inc. | Shark cartilage extract:process of making, methods of using and compositions thereof |
GB9621630D0 (en) * | 1996-10-17 | 1996-12-11 | Kappa Pharmaceuticals Ltd | Treatment of skin disorders |
EP0842670A1 (en) * | 1996-11-13 | 1998-05-20 | Katsunari Nishihara | Biomedical materials |
CA2288269A1 (en) | 1997-02-20 | 1998-08-27 | Industrial Research Limited | Angiogenesis inhibitors and activators from shark cartilage |
CN1824317A (zh) * | 1997-03-11 | 2006-08-30 | 阿特纳赞塔里斯公司 | 用于治疗肿瘤的含有鲨鱼软骨提取物和抗肿瘤剂的药物组合物 |
CA2295519C (en) * | 1997-07-11 | 2008-12-16 | Cv Technologies Inc. | A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
JPH11171782A (ja) * | 1997-12-03 | 1999-06-29 | Kaoru Yamane | 液体鮫軟骨の製造方法 |
FR2778558B1 (fr) * | 1998-05-12 | 2001-02-16 | Oreal | Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute |
US6168807B1 (en) * | 1998-07-23 | 2001-01-02 | Les Laboratoires Aeterna Inc. | Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
US20020009501A1 (en) * | 1998-07-23 | 2002-01-24 | Eric Dupont | Preparation of cartilage extracts using organic solvents |
AU5687199A (en) * | 1998-08-24 | 2000-03-14 | Global Vascular Concepts, Inc. | Use of anti-angiogenic agents for inhibiting vessel wall injury |
KR100355952B1 (ko) * | 2000-03-15 | 2002-10-11 | 주식회사 코리아나화장품 | 상어 연골추출물과 비타민 케이 유도체를 함유하는 화장료조성물 |
WO2001074320A2 (de) * | 2000-03-31 | 2001-10-11 | Henkel Kommanditgesellschaft Auf Aktien | Verwendung von protease-inhibitoren in der kosmetik und pharmazie |
WO2002049654A1 (en) * | 2000-12-20 | 2002-06-27 | Industrial Research Limited | Shark meat extract |
TWI233361B (en) | 2001-04-13 | 2005-06-01 | Gen Hospital Corp | Methods of preventing UVB-induced skin damage |
WO2003018620A2 (en) * | 2001-08-27 | 2003-03-06 | Les Laboratoires Aeterna Inc. | Serine protease inhibitor and processes for the preparation thereof |
US7504115B2 (en) | 2002-02-15 | 2009-03-17 | Ocean Nutrition Canada Limited | Shark cartilage extracts and use thereof for immunomodulation |
US20080063677A1 (en) * | 2004-03-10 | 2008-03-13 | New Life Resources, Llc | Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
JPWO2004083257A1 (ja) * | 2003-03-20 | 2006-06-22 | ホソカワミクロン株式会社 | 軟骨魚類から単離されたプロテオグリカンおよびその製造方法 |
US7067123B2 (en) * | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
US20050222687A1 (en) * | 2004-04-02 | 2005-10-06 | Gordana Vunjak-Novakovic | Cartilage implant assembly and method for implantation |
US20090291112A1 (en) * | 2003-05-16 | 2009-11-26 | Truncale Katherine G | Allograft osteochondral plug combined with cartilage particle mixture |
US7901457B2 (en) * | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
ES2223291B1 (es) * | 2003-08-06 | 2006-03-16 | Bioiberica, S.A. | Nuevo uso terapeutico de condroitin sulfato. |
ES2403357T3 (es) | 2003-12-11 | 2013-05-17 | Isto Technologies Inc. | Sistema de cartílago particulado |
CA2552607C (en) * | 2004-01-07 | 2012-04-17 | E-L Management Corporation | Cosmetic composition and method for retarding hair growth |
US8580315B2 (en) * | 2004-03-10 | 2013-11-12 | Esm Technologies, Llc | Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations |
US20050288796A1 (en) * | 2004-06-23 | 2005-12-29 | Hani Awad | Native soft tissue matrix for therapeutic applications |
US20080220044A1 (en) * | 2007-03-06 | 2008-09-11 | Semler Eric J | Cancellous construct with support ring for repair of osteochondral defects |
US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
US20090319045A1 (en) * | 2004-10-12 | 2009-12-24 | Truncale Katherine G | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
WO2006059236A2 (en) * | 2004-11-16 | 2006-06-08 | Aeterna Zentaris Inc. | Method of using cartilage extract for increasing blood parameters |
US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
JP4875865B2 (ja) * | 2005-08-17 | 2012-02-15 | 株式会社日本バリアフリー | 変形性関節症の予防及び治療用NTx値低減剤 |
JP5292533B2 (ja) | 2005-08-26 | 2013-09-18 | ジンマー・インコーポレイテッド | インプラントおよび関節疾患の治療、置換および治療方法 |
EP1926459B1 (en) | 2005-09-19 | 2015-01-07 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
US7951782B2 (en) | 2005-09-29 | 2011-05-31 | Maruha Nichiro Seafoods, Inc | Composition effective to prevent or treat adult disease |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
US20080154233A1 (en) * | 2006-12-20 | 2008-06-26 | Zimmer Orthobiologics, Inc. | Apparatus for delivering a biocompatible material to a surgical site and method of using same |
US8435551B2 (en) * | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
CA2684040C (en) * | 2007-04-12 | 2016-12-06 | Isto Technologies, Inc. | Method of forming an implant using a mold that mimics the shape of the tissue defect site and implant formed therefrom |
EP2224884A2 (en) * | 2007-12-05 | 2010-09-08 | Musculoskeletal Transplant Foundation | Cancellous bone implant for cartilage repair |
EP2262469A4 (en) * | 2008-04-15 | 2013-12-04 | Immanence Integrale Dermo Correction Inc | SKIN CARE COMPOSITIONS AND METHODS OF USE |
WO2012099216A1 (ja) * | 2011-01-19 | 2012-07-26 | 国立大学法人弘前大学 | プロテオグリカンの大量調製法 |
ES2604559T3 (es) | 2011-04-19 | 2017-03-07 | Bioiberica, S.A. | Producto de cartílago |
ES2403804B1 (es) * | 2011-09-21 | 2014-07-15 | Bioib�Rica, S.A. | Producto de cartílago. |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
RU2526825C1 (ru) * | 2013-06-18 | 2014-08-27 | Вера Геннадьевна Лихванцева | Фармацевтическая антиангиогенная композиция для лечения заболеваний глаз |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
CN104877009B (zh) * | 2015-05-11 | 2020-08-11 | 浙江海洋学院 | 一种赤魟软骨多肽类血管生成抑制因子 |
US20190365820A1 (en) | 2016-07-04 | 2019-12-05 | Kangstem Biotech Co., Ltd. | Complex for promoting cartilage differentiation comprising cartilage cell-free crush and stem cell and use thereof |
KR102154976B1 (ko) * | 2018-08-30 | 2020-09-11 | 전남대학교산학협력단 | 구내염 치료용 하이드로겔 |
KR102369902B1 (ko) * | 2021-04-23 | 2022-03-02 | 이수한 | 전 처리된 캐비아가 함유된 철갑상어 진액 및 그 제조 방법 |
KR20220166032A (ko) | 2021-06-09 | 2022-12-16 | 아스코코리아 주식회사 | 조립식 캠핑 테이블 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3478146A (en) * | 1965-02-26 | 1969-11-11 | Leslie L Balassa | Wound-healing cartilage powder extracting process |
US4042457A (en) * | 1975-11-10 | 1977-08-16 | Rush-Presbyterian-St. Luke's Medical Center | Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor |
US4822607A (en) * | 1976-10-29 | 1989-04-18 | Lescarden Ltd. | Anti-tumor agent and method |
US4243582A (en) * | 1979-04-26 | 1981-01-06 | Monsanto Company | Novel glycoproteins from bovine cartilage |
US4350682A (en) * | 1979-05-11 | 1982-09-21 | Lescarden Ltd. | Cartilage extraction processes and products |
US4356261A (en) * | 1980-04-22 | 1982-10-26 | Rush-Presbyterian-St. Luke's Medical Center | Anti-invasion factor containing cultures |
US4473551A (en) * | 1982-08-23 | 1984-09-25 | Faxon Pharmaceuticals, Inc. | Anti-inflammatory composition |
US4656137A (en) * | 1985-09-12 | 1987-04-07 | Lescarden Inc | Method of processing animal cartilage |
US4749522A (en) * | 1985-10-31 | 1988-06-07 | Angio-Medical Corporation | Supercritical fluid extraction of animal derived materials |
US4746729A (en) * | 1986-07-30 | 1988-05-24 | Kuettner Klaus E | Cartilage-derived leukocyte elastase-inhibitor |
US5075112A (en) * | 1990-02-12 | 1991-12-24 | Cartilage Technologies Inc. | Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage |
WO1994012510A1 (en) * | 1992-11-30 | 1994-06-09 | Lane I William | Processing shark cartilage |
ATE339975T1 (de) * | 1993-07-19 | 2006-10-15 | Angiotech Pharm Inc | Anti-angiogener stent und verfahren zu dessen herstellung |
US5618925A (en) * | 1994-04-28 | 1997-04-08 | Les Laboratories Aeterna Inc. | Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
JPH0870822A (ja) * | 1994-09-01 | 1996-03-19 | Makoma Kk | カプセル入り食品及びその製造法 |
AU717978B2 (en) * | 1995-02-03 | 2000-04-06 | Aeterna Zentaris Inc. | Extracts of shark cartilage, process of production and uses thereof |
-
1995
- 1995-10-30 US US08/550,003 patent/US6025334A/en not_active Expired - Fee Related
-
1996
- 1996-08-07 HU HU9802604A patent/HU225490B1/hu not_active IP Right Cessation
- 1996-08-07 BR BR9611507-6A patent/BR9611507A/pt not_active Application Discontinuation
- 1996-08-07 CN CNB961987634A patent/CN1187060C/zh not_active Expired - Lifetime
- 1996-08-07 CA CA002236021A patent/CA2236021C/en not_active Expired - Lifetime
- 1996-08-07 ZA ZA9606726A patent/ZA966726B/xx unknown
- 1996-08-07 AT AT96926300T patent/ATE230604T1/de not_active IP Right Cessation
- 1996-08-07 DE DE69625698T patent/DE69625698T2/de not_active Expired - Lifetime
- 1996-08-07 EP EP96926300A patent/EP0859622B1/en not_active Expired - Lifetime
- 1996-08-07 IL IL11903096A patent/IL119030A/xx not_active IP Right Cessation
- 1996-08-07 PL PL32688896A patent/PL187989B1/pl not_active IP Right Cessation
- 1996-08-07 RO RO98-00923A patent/RO118567B1/ro unknown
- 1996-08-07 NZ NZ313957A patent/NZ313957A/xx not_active IP Right Cessation
- 1996-08-07 CZ CZ981293A patent/CZ129398A3/cs unknown
- 1996-08-07 RU RU98110005/14A patent/RU2181292C2/ru active
- 1996-08-07 WO PCT/CA1996/000549 patent/WO1997016197A1/en not_active Application Discontinuation
- 1996-08-07 JP JP9516934A patent/JPH11513990A/ja active Pending
- 1996-08-07 DK DK96926300T patent/DK0859622T3/da active
- 1996-08-07 KR KR1019980703204A patent/KR100296016B1/ko not_active IP Right Cessation
- 1996-08-07 ES ES96926300T patent/ES2190475T3/es not_active Expired - Lifetime
- 1996-08-08 CO CO96042024A patent/CO4750839A1/es unknown
- 1996-08-09 IN IN1427CA1996 patent/IN188198B/en unknown
- 1996-10-01 TW TW085109647A patent/TW503108B/zh not_active IP Right Cessation
-
1998
- 1998-04-21 NO NO981781A patent/NO981781L/no not_active Application Discontinuation
- 1998-04-29 BG BG102419A patent/BG63907B1/bg unknown
- 1998-04-29 IS IS4728A patent/IS2017B/is unknown
- 1998-04-30 MX MX9803419A patent/MX9803419A/es unknown
-
1999
- 1999-02-23 HK HK99100722A patent/HK1015683A1/xx not_active IP Right Cessation
-
2003
- 2003-01-14 JP JP2003005998A patent/JP2003246740A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9802604A2 (hu) | Cápaporc extraktumok és eljárás előállításukra | |
BR9510540A (pt) | Extratos de cartilagem de tubarão processo de produção e usos dos mesmos | |
BR0013897A (pt) | Uso de ácido linoleico conjugado (cla) ou de um seu derivado, composição tópica cosmética ou dermatológica, e, método de tratamento e/ou de profilaxia de celulite e de depósitos de gordura | |
DE60136348D1 (de) | Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten | |
ATE297213T1 (de) | Sojaextrakt, verfahren zu dessen herstellung und pharmazeutische zusammensetzung | |
Gupta et al. | Antiallergic activity of arbortristosides from Nyctanthus arbortristis | |
JPH03151315A (ja) | アロエ水及びその製造方法 | |
Kim et al. | Coumarin glycosides from the roots of Angelica dahurica | |
ITPD920142A1 (it) | Esteri di gellano autoreticolato, procedimento di preparazione e loro applicazioni farmaceutiche e biomedico-sanitarie | |
KR102348275B1 (ko) | 피부 자극 완화 및 항염 효능을 갖는 화장료 조성물 | |
BR9907837B1 (pt) | composiÇço cosmÉtica, processo de preparaÇço de um produto extraÍdo com atividade estimuladora da produÇço de il-6 pelos queratinàcitos, utilizaÇço do mesmo e utilizaÇço de uma cepa de rhodotorula. | |
KR102139600B1 (ko) | 지의류 유래의 추출 성분을 포함하는 항 염증 조성물 | |
KR102294091B1 (ko) | 아티초크 잎 및 일라이트를 유효성분으로 포함하는 화장료 조성물 및 그 제조방법 | |
JP2018177702A (ja) | ノリウツギ抽出物を有効成分とする皮膚老化防止剤及びそれを含有する皮膚外用剤 | |
Nasser | Phytochemicals: Extraction, Isolation & Identification of Bioactive Compounds from Aristolochia bracteolate | |
JP2024074682A (ja) | Fgf21受容体発現亢進剤 | |
GEU20031035Y (en) | Method for Production of Aloe Extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |